Invention Grant
- Patent Title: CD200 inhibitors and methods of use thereof
-
Application No.: US17845916Application Date: 2022-06-21
-
Publication No.: US11666645B2Publication Date: 2023-06-06
- Inventor: Michael Olin
- Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
- Applicant Address: US MN Minneapolis
- Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
- Current Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
- Current Assignee Address: US MN Minneapolis
- Agency: Viksnins Harris Padys Malen LLP
- The original application number of the division: US15773527
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/39 ; C07K7/06 ; C07K7/08 ; C07K14/705 ; A61P35/02 ; A61K9/00 ; A61K31/203 ; A61K31/404 ; A61K31/675 ; A61K31/7068 ; A61K38/20
Abstract:
The present invention provides in certain embodiments compositions comprising at least one CD200 inhibitor, and methods of reversing or modulating immune suppression in a patient having a disease or disorder arising from abnormal cell growth, function or behavior, which method comprises administering to a patient in need thereof a CD200 inhibitor composition.
Public/Granted literature
- US20220347280A1 CD200 INHIBITORS AND METHODS OF USE THEREOF Public/Granted day:2022-11-03
Information query
